Katherine A. Eade
Board Member
Harvard Bioscience Inc (HBIO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Katherine A. Eade
Katherine A. Eade is recorded as Board Member at Harvard Bioscience Inc (HBIO). Harvard Bioscience Inc reported in an 8-K filed June 2, 2026 that Katherine A. Eade was appointed Class II Director, effective June 2, 2026.
“The Company's stockholders elected two Class II Directors for three-year terms, such terms to continue until the annual meeting of stockholders in 2029 and until such Directors' successors are duly elected and qualified or until his or her earlier resignation or removal:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-06-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Harvard Bioscience Inc
Other people whose current roles at this company are on record from its filings.
- Former Chairman CEO
- John Duke CEO, Board Member
- Katherine Eade Chairman
- Mark Frost CFO
- Kenneth Olson COO
- Bertrand Loy Board Member
- Bill Snider Board Member
- John D. Duke Board Member
- Mr. William A. Snider Board Member
- Rob Gagnon Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.